Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
152.43
-2.15 (-1.39%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ascendis Pharma Analyst Ratings
Total Analysts
14
Consensus Rating
Strong Buy
Price Target
$197.36
Upside
+29.48%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $220 → $260 | Buy | Maintains | $220 → $260 | +70.57% | Feb 18, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $200 → $225 | Strong Buy | Maintains | $200 → $225 | +47.61% | Feb 13, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $167 → $168 | Buy | Maintains | $167 → $168 | +10.21% | Feb 13, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $170 | Buy | Reiterates | $170 | +11.53% | Feb 11, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $165 → $167 | Buy | Maintains | $165 → $167 | +9.56% | Jan 29, 2025 |
| UBS | UBS | Strong Buy Initiates $196 | Strong Buy | Initiates | $196 | +28.58% | Jan 7, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $160 → $153 | Strong Buy | Maintains | $160 → $153 | +0.37% | Nov 15, 2024 |
| Wedbush | Wedbush | Buy Reiterates $181 | Buy | Reiterates | $181 | +18.74% | Nov 15, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $190 → $180 | Buy | Maintains | $190 → $180 | +18.09% | Nov 15, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $170 | Buy | Reiterates | $170 | +11.53% | Nov 15, 2024 |
| Stifel | Stifel | Strong Buy Maintains $200 → $207 | Strong Buy | Maintains | $200 → $207 | +35.80% | Nov 15, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $170 | Buy | Reiterates | $170 | +11.53% | Nov 4, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $180 → $174 | Buy | Maintains | $180 → $174 | +14.15% | Oct 23, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $157 → $160 | Strong Buy | Maintains | $157 → $160 | +4.97% | Oct 21, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $175 → $191 | Strong Buy | Maintains | $175 → $191 | +25.30% | Sep 23, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $264 → $289 | Buy | Maintains | $264 → $289 | +89.60% | Sep 17, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.